Total Payments
$16,795
2024 Payments
$2,479
Companies
83
Transactions
1,020
Medicare Patients
3,895
Medicare Billing
$411,379
Payment Breakdown by Category
Food & Beverage$16,764 (99.8%)
Education$30.83 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,764 | 1,011 | 99.8% |
| Education | $30.83 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,602 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,295 | 81 | $0 (2024) |
| ABBVIE INC. | $1,193 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,097 | 65 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,027 | 32 | $0 (2024) |
| Amgen Inc. | $861.60 | 53 | $0 (2024) |
| PFIZER INC. | $853.70 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $716.11 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $664.28 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $573.59 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,479 | 120 | Supernus Pharmaceuticals, Inc. ($554.47) |
| 2023 | $2,306 | 129 | AbbVie Inc. ($264.93) |
| 2022 | $2,804 | 154 | Lilly USA, LLC ($303.65) |
| 2021 | $2,239 | 143 | AbbVie Inc. ($267.62) |
| 2020 | $1,344 | 86 | AstraZeneca Pharmaceuticals LP ($185.90) |
| 2019 | $1,934 | 128 | AstraZeneca Pharmaceuticals LP ($276.23) |
| 2018 | $1,894 | 122 | Novo Nordisk Inc ($452.61) |
| 2017 | $1,794 | 138 | Janssen Pharmaceuticals, Inc ($194.61) |
All Payment Transactions
1,020 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: PAIN | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: ANTIBIOTIC | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,019 | 1,497 | $245,578 | $98,276 |
| 2022 | 11 | 948 | 1,339 | $240,712 | $104,664 |
| 2021 | 14 | 1,048 | 1,500 | $257,103 | $117,939 |
| 2020 | 15 | 880 | 1,280 | $214,868 | $90,500 |
Total Patients
3,895
Total Services
5,616
Medicare Billing
$411,379
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 483 | $120,750 | $39,394 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $40,250 | $19,643 | 48.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 147 | 147 | $14,700 | $11,166 | 76.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 164 | $28,700 | $8,724 | 30.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 111 | $10,656 | $5,293 | 49.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 26 | $8,320 | $3,913 | 47.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 159 | 159 | $5,565 | $2,766 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 19 | $6,175 | $2,314 | 37.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 62 | $4,402 | $2,177 | 49.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 19 | 37 | $2,109 | $958.57 | 45.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 21 | 22 | $1,100 | $821.13 | 74.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 22 | 48 | $1,200 | $719.76 | 60.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 35 | $1,260 | $335.42 | 26.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 23 | $391.00 | $50.60 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 523 | $117,580 | $42,510 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 167 | 167 | $41,750 | $21,108 | 50.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 171 | 172 | $17,200 | $13,470 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 121 | $18,800 | $6,985 | 37.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 34 | 42 | $13,440 | $6,162 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 45 | $15,575 | $5,404 | 34.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 170 | 170 | $5,950 | $2,991 | 50.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $3,750 | $2,429 | 64.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $3,250 | $1,962 | 60.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 21 | 56 | $3,192 | $1,611 | 50.5% |
| 81005 | Analysis of urine, except immunoassays | Office | 2022 | 15 | 15 | $225.00 | $32.05 | 14.2% |
About Dr. John Scheitler, MD
Dr. John Scheitler, MD is a Internal Medicine healthcare provider based in Gastonia, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093786360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Scheitler, MD has received a total of $16,795 in payments from pharmaceutical and medical device companies, with $2,479 received in 2024. These payments were reported across 1,020 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($16,764).
As a Medicare-enrolled provider, Scheitler has provided services to 3,895 Medicare beneficiaries, totaling 5,616 services with total Medicare billing of $411,379. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Gastonia, NC
- Active Since 01/27/2006
- Last Updated 02/17/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093786360
Products in Payments
- FARXIGA (Drug) $702.59
- Ozempic (Drug) $617.70
- Qelbree (Drug) $554.47
- VRAYLAR (Drug) $547.38
- Kerendia (Drug) $521.48
- NURTEC ODT (Drug) $508.74
- XARELTO (Drug) $489.75
- QELBREE (Drug) $456.89
- TRULICITY (Drug) $425.02
- MOUNJARO (Drug) $420.80
- Saxenda (Drug) $412.35
- UBRELVY (Drug) $407.71
- Natesto (Drug) $336.29
- Aimovig (Biological) $334.24
- BEXSERO (Biological) $298.98
- Livalo (Drug) $282.09
- QULIPTA (Drug) $278.95
- JARDIANCE (Drug) $268.65
- NEXLETOL (Drug) $228.07
- Doc Band (Device) $223.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gastonia
Stephen Burgess, M.d, M.D
Internal Medicine — Payments: $232,000
Internal Medicine $232,000
Dr. Greg Robicheaux, M.d, M.D
Internal Medicine — Payments: $38,000
Internal Medicine $38,000
Mr. Johnathan Williams, Md, MD
Internal Medicine — Payments: $14,623
Internal Medicine $14,623
Dr. Stephan Hewitt, M.d, M.D
Internal Medicine — Payments: $13,089
Internal Medicine $13,089
Ram Belbase, M.d, M.D
Internal Medicine — Payments: $10,697
Internal Medicine $10,697
Azeem Elahi, Md, MD
Internal Medicine — Payments: $9,540
Internal Medicine $9,540